The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Robert G. Masterton

Ayrshire & Arran NHS Board

The Ayr Hospital



Name/email consistency: high



  • Ayrshire & Arran NHS Board, The Ayr Hospital, UK. 2007 - 2009
  • Department of Microbiology, Crosshouse Hospital, Kilmarnock, UK. 2008
  • Ayrshire and Arran National Health Service Board, The Ayr Hospital, Ayr, United Kingdom. 2008
  • NHS Ayrshire and Arran, Eglington House, Ailsa Hospital, Dalmellington Road, USA. 2007
  • Crosshouse Hospital, Kilmarnock, Aryshire, UK. 2006
  • Ayrshire and Arran Acute Hospitals Trust, Crosshouse Hospital, Crosshouse Kilmarnock, Ayrshire, UK. 2003 - 2005


  1. The new treatment paradigm and the role of carbapenems. Masterton, R.G. Int. J. Antimicrob. Agents (2009) [Pubmed]
  2. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Masterton, R.G., Galloway, A., French, G., Street, M., Armstrong, J., Brown, E., Cleverley, J., Dilworth, P., Fry, C., Gascoigne, A.D., Knox, A., Nathwani, D., Spencer, R., Wilcox, M. J. Antimicrob. Chemother. (2008) [Pubmed]
  3. The importance and future of antimicrobial surveillance studies. Masterton, R. Clin. Infect. Dis. (2008) [Pubmed]
  4. The place of guidelines in hospital-acquired pneumonia. Masterton, R. J. Hosp. Infect. (2007) [Pubmed]
  5. Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development. Masterton, R., Craven, D., Rello, J., Struelens, M., Frimodt-Moller, N., Chastre, J., Ortqvist, A., Cornaglia, G., Lode, H., Giamarellou, H., Bonten, M.J., Eraksoy, H., Davey, P. J. Antimicrob. Chemother. (2007) [Pubmed]
  6. Improving practice--the Hospital Pharmacy Initiative revisited. Masterton, R.G., Caldwell, M. J. Antimicrob. Chemother. (2007) [Pubmed]
  7. Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002). Masterton, R.G., Turner, P.J. Int. J. Antimicrob. Agents (2006) [Pubmed]
  8. The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe. Masterton, R.G., Kuti, J.L., Turner, P.J., Nicolau, D.P. J. Antimicrob. Chemother. (2005) [Pubmed]
  9. Antibiotic cycling: more than it might seem?. Masterton, R.G. J. Antimicrob. Chemother. (2005) [Pubmed]
  10. Review of hospital isolation and infection control precautions. Masterton, R.G., Mifsud, A.J., Rao, G.G. J. Hosp. Infect. (2003) [Pubmed]
  11. Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. Masterton, R., Drusano, G., Paterson, D.L., Park, G. J. Hosp. Infect. (2003) [Pubmed]
WikiGenes - Universities